Jiangsu Yingke Biopharmaceutical

Jiangsu Yingke Biopharmaceutical is a specialized pharmaceutical company based in China's Medical City, Taizhou, focusing on the development and production of high-end injectable emulsions. The company has established a leading position in the anesthesia and sedation market through its expertise in lipid emulsion drug delivery technology. Its commercial portfolio includes Propofol Injectable Emulsion (MCT/LCT) and Etomidate Injectable Emulsion, which are widely used in perioperative care. Yingke Biopharmaceutical maintains state-of-the-art GMP manufacturing facilities and continues to expand its pipeline into cardiovascular and nutritional therapies. The firm is dedicated to providing high-quality, complex injectables that improve clinical outcomes for patients undergoing surgery or intensive care.